Erratum to: The epigenetic signature of systemic insulin resistance in obese women.
Department of Medicine, Karolinska Institutet, Karolinska University Hospital, C2:94, Huddinge, S-141 86, Stockholm, Sweden.
Peter
P
Arner
GlaxoSmithKline R&D, Stevenage, UK.
Anna-Stina
AS
Sahlqvist
Department of Biosciences and Nutrition, Karolinska Institutet, Stockholm, Sweden.
Indranil
I
Sinha
GlaxoSmithKline R&D, Research Triangle Park, NC, USA.
Huan
H
Xu
Computational and Systems Biology, Discovery Sciences, Janssen Pharmaceutical, Research & Development, LLC, San Diego, CA, USA.
Xiang
X
Yao
GlaxoSmithKline R&D, King of Prussia, PA, USA.
Dawn
D
Waterworth
GlaxoSmithKline R&D, King of Prussia, PA, USA.
Deepak
D
Rajpal
Pfizer Worldwide Research and Development, Groton, CT, USA.
A Katrina
AK
Loomis
GlaxoSmithKline R&D, King of Prussia, PA, USA.
Johannes M
JM
Freudenberg
GlaxoSmithKline R&D, Stevenage, UK.
Toby
T
Johnson
Department of Surgery, Ersta Hospital, Stockholm, Sweden.|Department of Clinical Sciences, Karolinska Institutet, Danderyd Hospital, Danderyd, Sweden.
Anders
A
Thorell
Department of Clinical Sciences, Karolinska Institutet, Danderyd Hospital, Danderyd, Sweden.
Erik
E
Näslund
Department of Medicine, Karolinska Institutet, Karolinska University Hospital, C2:94, Huddinge, S-141 86, Stockholm, Sweden.
Mikael
M
Ryden
Department of Medicine, Karolinska Institutet, Karolinska University Hospital, C2:94, Huddinge, S-141 86, Stockholm, Sweden. ingrid.dahlman@ki.se.
Ingrid
I
Dahlman